@Testiscancer

Senior testis cancer doc. Founder testicular cancer commons, PI S1823, mentor of youngsters, father of farmers. Opinions my own

 Portland, Oregon
testicularcancercommons.org
Joined June 2009
  • Tweets1.3K
  • Following468
  • Followers836
12Media
Replying to @Caba_L @uroegg @dr_coops @ChapinMD @SimaPorten @Scarps_kristen @mdallera @DanLinMD @wandering_gu @uretericbud @AnneSchuckmanMD @pcvblack @DanBarocas @LoebStacy @daviesbj @urogeek @cjkane10 @SurenaMatinMD
Willamette!!
1
1
3
833
Craig Nichols retweeted
Sean McBride
@seanmmcbride20 Mar 2023
Replying to @MaartenAlbersen @Testiscancer
I was just responding to ethics of randomization. Of course could leave up to patient as a way to encourage accrual, but non randomization has obvious downsides. Can you send clinical trials.gov link for Magestic?
1
1
1
739
How Do You Best Treat Early Metastatic Seminoma: for Surgery @siadaneshmand @USC -Can we reduce the long-term toxicities of chemo and radiation? -Relapse rate low, OS 100%! #GU23 @ASCO @OncoAlert @urotoday @OncBrothers @HemOncFellows @Uromigos #MedTwitter @Uroweb @TCSociety
3
1
4
4,765
Replying to @Testiscancer
If you are going to turn this into „I am the better physician“, I am no longer going to discuss with you. Show me the evidence of Carbo-toxicity. The study you quote has inadequate follow-up (med.2y). The shorter the follow-up, the shorter the median time to recurrence.
2
1
1
8
1,467
Replying to @CDFankhauser @siadaneshmand @UroAlsyouf @AdityaBagrodia @Testiscancer @LuciaNappi4 @GU_BigWhacks @drphil_urology @uroegg @SBoorjian @TCSociety @robert_huddart @royalmarsdenNHS
Yes, carbo appears key to making RPLnD (robotic) a very good option
1
2
1,354
10/ In the phase 2 #SAKK 01/10 trial, single-dose carboplatin followed by involved-node RT in stage II #seminoma showed a favorable efficacy and toxicity profile with 93.7% PFS at 3 years. @Alex_Papachris @SAKK_ch @TheLancetOncol
2
4
2
33
7,096
Replying to @Testiscancer
Depending on the type, depth and platform RNA and DNA sequencing is about the same cost, RNA slightly more expensive in some cases and definitely more technical! Reference check!
1
1
1
Dr. @LuciaNappi4 from the @VanProstateCtr received an award from the US @DeptofDefense for her study on detecting early relapse in patients with early stage testicular #GermCell tumours. 🔬 Learn more: bit.ly/3TajHEm
3
15
Craig Nichols retweeted
David Sable@dbsable12 Aug 2022
Usual master class in expository writing from @daviesbj. More importantly, an eloquent reality check from the front lines of clinical care in urology.
Benjamin J. Davies MD, MBA
@daviesbj11 Aug 2022
Waiting for the Robot by Benjamin Davies MD auajournals.org/doi/10.1097/…
2
3
15
Craig Nichols retweeted
SPStroup@spstroup25 Jun 2022
It has been a great honor to serve my country in the Unites States Navy for 21 years. I offer my heartfelt gratitude to the Naval Medical Center San Diego Department of Urology physicians – past and present, residents, staff, and patients. @NavyMedicine @NMC_SD
6
2
54
Sir Michael Peckham obituary. Oncologist who pioneered modern treatments for testicular cancer – the jockey Bob Champion was one of his patients theguardian.com/science/2021…
2
4
Craig Nichols retweeted
Shawn Dason
@shawndason12 Sep 2021
Replying to @Testiscancer
What is the proportion of patients undergoing primary rplnd that are relapses on AS vs upfront diagnoses? All I’m saying is my guess that many referrals for a primary rplnd will not necessarily come from medical oncology. I don’t know what data exists to support that hypothesis.
1
1
1
Craig Nichols retweeted
Shawn Dason
@shawndason12 Sep 2021
Replying to @Testiscancer
Not really a robotic rplnd enthusiast at all and I support multidisciplinary care…but my guess is most robotic rplnds are probably primary and you wouldn’t control the referrals.
1
1
1
Replying to @Testiscancer
Fair for noninferior design if onc primary endpt. But for periop outcome can be superiority. Also level 1 data showing R-RPLND is a good option in exp hands is important as it becomes common. I welcome this data as I prefer Robo. Would also accept neg result In high quality trial
1
1
A call to raise the bar in oncology: focus on value, limitations of evidence, avoidance of bias, research design and sound regulatory process. Important and relevant well beyond cancer. nature.com/articles/s41416-0…
3
15
For a better explanation of what is wrong with this paper--- MRI-Targeted or Standard Biopsy in Prostate Cancer Screening-- check out my video below 👇👇👇 @Plenary_Session youtu.be/3BEgnoH07uI

I review the new MRI guided prostate bx paper in NEJM

MRI-Targeted or Standard Biopsyin Prostate Cancer Screeninghttps:...

youtube.com
3
1
12
Central review/oversight & standardization of care is THE most important step in reducing morbidity/mortality due to #testicularcancer #tscsm Is your system doing it? Kaiser Permanente Northern California's Testicular Cancer Review Panel is. k-p.li/3cSoibm 👏 @aboutKP
2
5
Central review/oversight & standardization of care is THE most important step in reducing morbidity/mortality due to #testicularcancer #tscsm Is your system doing it? Kaiser Permanente Northern California's Testicular Cancer Review Panel is. k-p.li/3cSoibm 👏 @kpnorcal
3
1
Craig Nichols retweeted
DrBagrodia@AdityaBagrodia24 Jun 2021
Replying to @UTSWUrology
I cannot thank the @UTSWUrology graduated chiefs enough for this incredible honor. It is the highlight of my professional career. Our incredible residents, fellows, and med students make teaching a joy. And thanks to all for the well wishes!
2
14
Late relapse of germ cell tumors by Noah Hunter Richardson @IndianaUniv 🔶Most pts with chemo-exposed LR will be diagnosed with an elevated AFP! 🔶GCT pts require lifetime FU with annual PE and tumor markers @ASCO @OncoAlert @TCSociety #ASCO21 #cancersurvivor @Uroweb @urotoday
10
24
Load more